The combination of all three (triple agonism) is the design hypothesis: act on appetite, insulin, and energy burn together, with the molecule tuned to be roughly nine times more active at the GIP receptor than the body's own GIP hormone, and somewhat less strongly active at the other two [2]
10.1161/01.RES.80.3.383 46 JohnsonM
Furthermore, research concludes that it might mediate NO release, inhibit infammation and trigger the synthesis of growth factors
And when you see the numbers like that, choosing protein kind of feels like a no-brainer, right
One of the defining characteristics of TB500 research is its relationship with the cytoskeleton the internal framework that helps cells maintain shape, move, and respond to environmental signals
These probabilities matter when you are deciding which medication to try first, because time spent on a less effective option is time without the metabolic benefits a more effective option might provide